{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:10:20Z","timestamp":1761577820421,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["09\/844(0048)\/2018"],"award-info":[{"award-number":["09\/844(0048)\/2018"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["09\/844(0048)\/2018"],"award-info":[{"award-number":["09\/844(0048)\/2018"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["09\/844(0048)\/2018"],"award-info":[{"award-number":["09\/844(0048)\/2018"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.meegid.2021.104824","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T11:55:34Z","timestamp":1616673334000},"page":"104824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients"],"prefix":"10.1016","volume":"92","author":[{"given":"Prakhar","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthikeyan","family":"Sivashanmugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.meegid.2021.104824_bb0005","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/00365540110027222","article-title":"Investigation of synergism of meropenem and ciprofloxacin against Pseudomonas aeruginosa and Acinetobacter strains isolated from intensive care unit infections","volume":"33","author":"American","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.meegid.2021.104824_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1524-475X.2007.00283.x","article-title":"Why chronic wounds will not heal: a novel hypothesis","volume":"16","author":"Bjarnsholt","year":"2008","journal-title":"Wound Repair Regen."},{"issue":"5","key":"10.1016\/j.meegid.2021.104824_bb0015","first-page":"1007","article-title":"Diabetic foot ulcers. Pathophysiology, assessment, and therapy","volume":"47","author":"Bowering","year":"2001","journal-title":"Can. Fam. Physician"},{"issue":"3","key":"10.1016\/j.meegid.2021.104824_bb0020","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijantimicag.2017.11.003","article-title":"Ceftolozane\/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes","volume":"51","author":"Dietl","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"10.1016\/j.meegid.2021.104824_bb0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2147\/tcrm.2006.2.4.401","article-title":"Fish. Meropenem in the treatment of complicated skin and soft tissue infections","volume":"2","author":"Douglas","year":"2006","journal-title":"Ther. Clin. Risk Manag."},{"issue":"6","key":"10.1016\/j.meegid.2021.104824_bb0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/mdr.2014.0006","article-title":"In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa","volume":"20","author":"D\u2019Souza","year":"2014","journal-title":"Microb. Drug Resist."},{"issue":"6","key":"10.1016\/j.meegid.2021.104824_bb0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7547\/15-167","article-title":"Risk factors for infection with Pseudomonas aeruginosa in diabetic foot infections","volume":"107","author":"Ertugrul","year":"2017","journal-title":"J. Am. Podiatr. Med. Assoc."},{"issue":"14","key":"10.1016\/j.meegid.2021.104824_bb0040","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnx142","article-title":"Optimization of therapy against Pseudomonas aeruginosa with ceftazidime and meropenem using chemostats as a model for infections","volume":"364","author":"Feng","year":"2017","journal-title":"FEMS Microbiol. Lett."},{"issue":"19","key":"10.1016\/j.meegid.2021.104824_bb0045","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.meegid.2021.104824_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkz228","article-title":"Potentiation of \u03b2-lactam antibiotics and \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against MDR and XDR Pseudomonas aeruginosa using non-ribosomal tobramycin\u2013cyclam conjugates","author":"Idowu","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.meegid.2021.104824_bb0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0732-8893(98)00126-6","article-title":"In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with \u03b2-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia capacity","volume":"33","author":"Isenberg","year":"1999","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.meegid.2021.104824_bb0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.arcmed.2005.01.003","article-title":"Pathogenesis of type 2 diabetes mellitus","volume":"36","author":"Leahy","year":"2005","journal-title":"Arch. Med. Res."},{"issue":"3","key":"10.1016\/j.meegid.2021.104824_bb0065","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2337\/dc13-2510","article-title":"Treating diabetic foot osteomyelitis primarily with surgery or antibiotics: have we answered the question?","volume":"37","author":"Lipsky","year":"2014","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.meegid.2021.104824_bb0070","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1128\/AAC.02109-13","article-title":"Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia","volume":"58","author":"Luyt","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.meegid.2021.104824_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00267-17","article-title":"Pharmacodynamics of cefepime combined with tazobactam against clinically relevant Enterobacteriaceae in a neutropenic mouse thigh model","volume":"61","author":"Melchers","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.meegid.2021.104824_bb0080","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1128\/AAC.00220-16","article-title":"In vitro susceptibility of global surveillance isolates of Pseudomonas aeruginosa to ceftazidime-avibactam (INFORM 2012 to 2014)","volume":"60","author":"Nichols","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104824_bb0085","first-page":"2014","article-title":"The visualization of biofilms in chronic diabetic foot wounds using routine diagnostic microscopy methods","author":"Oates","year":"2014","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.meegid.2021.104824_bb0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1469-0691.1997.tb00254.x","article-title":"Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against gram-positive and gram-negative bacteria","volume":"3","author":"Odenholt","year":"1997","journal-title":"Clin. Microbiol. Infect."},{"issue":"8","key":"10.1016\/j.meegid.2021.104824_bb0095","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/dia.2012.0039","article-title":"Microbial profile and utility of soft tissue, pus, and bone cultures in diagnosing diabetic foot infections","volume":"14","author":"Parvez","year":"2012","journal-title":"Diabetes Technol. Ther."},{"issue":"2","key":"10.1016\/j.meegid.2021.104824_bb0100","article-title":"Interactions of methicillin-resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in polymicrobial wound infection","volume":"8","author":"Pastor","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.meegid.2021.104824_bb0105","first-page":"443","article-title":"Prevalence of extended-spectrum \u03b2-Lactamases in multi-drug resistant Pseudomonas aeruginosa from diabetic foot patients","volume":"19","author":"Qudus","year":"2019","journal-title":"Endoc. Metabol. Immune Disord.-Drug Targets (Form. Curr. Drug Targets-Immune Endoc. Metabol. Disord.)"},{"issue":"3","key":"10.1016\/j.meegid.2021.104824_bb0110","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00248-016-0867-9","article-title":"Bacterial contribution in the chronicity of wounds","volume":"73","author":"Rahim","year":"2017","journal-title":"Microb. Ecol."},{"issue":"11","key":"10.1016\/j.meegid.2021.104824_bb0115","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01150-18","article-title":"Meropenem combined with ciprofloxacin combats hypermutable Pseudomonas aeruginosa from respiratory infections of cystic fibrosis patients","volume":"62","author":"Rees","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104824_bb0120","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3389\/fmicb.2015.01464","article-title":"Isolation and genetic analysis of multidrug-resistant bacteria from diabetic foot ulcers","volume":"6","author":"Shahi","year":"2016","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.meegid.2021.104824_bb0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bjm.2017.09.003","article-title":"Epidemiology of diabetic foot infections in a reference tertiary hospital in India","volume":"49","author":"Sreedharan","year":"2018","journal-title":"Braz. J. Microbiol."},{"issue":"1","key":"10.1016\/j.meegid.2021.104824_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1534734619873785","article-title":"Combinatorial drug therapy for controlling Pseudomonas aeruginosa and its association with the chronic condition of diabetic foot ulcer","volume":"19","author":"Srivastava","year":"2020","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.meegid.2021.104824_bb0135","doi-asserted-by":"crossref","first-page":"106071","DOI":"10.1016\/j.dib.2020.106071","article-title":"Comparative data analysis of two multi-drug resistant homoserine lactone and rhamnolipid producing Pseudomonas aeruginosa from diabetic foot infected patient","volume":"32","author":"Srivastava","year":"2020","journal-title":"Data Brief."},{"issue":"3","key":"10.1016\/j.meegid.2021.104824_bb0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1534734606291676","article-title":"Clinical and microbiological efficacy of colistin therapy in combination with rifampin and imipenem in multidrug-resistant Pseudomonas aeruginosa diabetic foot infection with osteomyelitis","volume":"5","author":"Tasini","year":"2006","journal-title":"Int J Low Extrem Wounds"},{"issue":"3","key":"10.1016\/j.meegid.2021.104824_bb0145","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1590\/S1517-83822012000300020","article-title":"Preparation, characterization, and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains","volume":"43","author":"Torres","year":"2012","journal-title":"Braz. J. Microbiol."},{"key":"10.1016\/j.meegid.2021.104824_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/173053","article-title":"Prevalence of multiple antibiotic-resistant infections in diabetic versus non-diabetic wounds","volume":"2014","author":"Trivedi","year":"2014","journal-title":"J. Pathogens."},{"issue":"3","key":"10.1016\/j.meegid.2021.104824_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13060","article-title":"Association Between Biofilm And Multi\/Extensive Drug Resistance in Diabetic Foot Infection","volume":"72","author":"Vatan","year":"2018","journal-title":"Intern. J. Clin. Pract."},{"issue":"3","key":"10.1016\/j.meegid.2021.104824_bb0160","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40121-016-0121-2","article-title":"Evaluation of pharmacodynamic interactions between telavancin and aztreonam or piperacillin\/tazobactam against Pseudomonas aeruginosa, Escherichia coli, and methicillin-resistant Staphylococcus aureus","volume":"5","author":"Yim","year":"2016","journal-title":"Infect. Dis. Ther."},{"issue":"5","key":"10.1016\/j.meegid.2021.104824_bb0165","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/1120009X.2016.1140858","article-title":"Targeted benefits of prolonged-infusion piperacillin-tazobactam in an in vitro infection model of Pseudomonas aeruginosa","volume":"28","author":"Zelenitsky","year":"2016","journal-title":"J. Chemother."},{"issue":"5","key":"10.1016\/j.meegid.2021.104824_bb0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1524-475X.2010.00608.x","article-title":"Delayed wound healing in diabetic (DB\/DB) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds","volume":"18","author":"Zhao","year":"2010","journal-title":"Wound Repair Regen."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821001210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821001210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:51:21Z","timestamp":1761576681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134821001210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":34,"alternative-id":["S1567134821001210"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104824","relation":{},"ISSN":["1567-1348"],"issn-type":[{"type":"print","value":"1567-1348"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104824"}}